|
業務類別
|
Drug Manufacturers - General |
|
業務概覽
|
Amarin Corp PLC is a pharmaceutical company. The company is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa. The company focuses on treatments to stop cardiovascular disease causing death, by providing patients, doctors and investors with reliable cardiovascular treatment options. Geographically, the company derives maximum revenue from United States. |
| 公司地址
| 36 Dame Street, 8th Floor, One Central Plaza, Dublin, IRL, D02 K7K5 |
| 電話號碼
| +353 16699020 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.amarincorp.com |
| 員工數量
| 80 |
| Dr. Steven B. Ketchum, PhD |
Executive Vice President, President, Research and Development and Chief Scientific Officer |
美元 687.49K |
10/04/2026 |
| Mr. Aaron D. Berg |
Director, President and Chief Executive Officer |
美元 725.67K |
10/04/2026 |
| Mr. Jonathan N. Provoost |
Executive Vice President, Chief Legal and Compliance Officer and Secretary |
美元 484.18K |
10/04/2026 |
| Mr. Peter Fishman |
Senior Vice President, Chief Financial Officer and Principal Accounting Officer |
美元 400.00K |
10/04/2026 |
| Dr. David Paul Keenan, PhD |
Executive Vice President and Chief Operating Officer |
美元 452.69K |
10/04/2026 |
|
|
| Dr. Odysseas D. Kostas, M.D. |
Chairman of the Board |
10/04/2026 |
| Mr. Aaron D. Berg |
Director, President and Chief Executive Officer |
10/04/2026 |
| Mr. Keith L. Horn |
Independent Director |
10/04/2026 |
| Ms. Patrice Bonfiglio |
Independent Director |
10/04/2026 |
| Dr. Paul Cohen, M.D. |
Independent Director |
27/03/2026 |
| Mr. Louis Sterling, III |
Independent Director |
10/04/2026 |
| Ms. Diane E. Sullivan |
Independent Director |
10/04/2026 |
| Mr. Michael Torok |
Director |
10/04/2026 |
|
|
|
|
